APA (7th ed.) Citation

Susiriwatananont, T., Eiamprapaporn, P., Vazquez Roque, M., Farraye, F. A., Perlman, A., & Chumsri, S. (2025). The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists. Cells (2073-4409), 14(22), 1779. https://doi.org/10.3390/cells14221779

Chicago Style (17th ed.) Citation

Susiriwatananont, Thiti, Panuch Eiamprapaporn, Maria Vazquez Roque, Francis A. Farraye, Adam Perlman, and Saranya Chumsri. "The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists." Cells (2073-4409) 14, no. 22 (2025): 1779. https://doi.org/10.3390/cells14221779.

MLA (9th ed.) Citation

Susiriwatananont, Thiti, et al. "The Gut Microbiome as a Biomarker and Therapeutic Target of Immune Checkpoint Inhibitors: A Review for Oncologists." Cells (2073-4409), vol. 14, no. 22, 2025, p. 1779, https://doi.org/10.3390/cells14221779.